<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/dataseer-ml/../grobid-home/schemas/xsd/Grobid.xsd">
  <teiHeader xml:lang="en">
    <encodingDesc>
      <appInfo>
        <application ident="GROBID" version="0.5.6-SNAPSHOT" when="2019-11-05T20:37+0000">
          <ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
        </application>
      </appInfo>
    </encodingDesc>
    <fileDesc>
      <titleStmt>
        <title level="a" type="main">Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples</title>
      </titleStmt>
      <publicationStmt>
        <publisher/>
        <availability status="unknown">
          <licence/>
        </availability>
      </publicationStmt>
      <sourceDesc>
        <biblStruct>
          <analytic>
            <author>
              <persName>
                <forename type="first">Dinesh</forename>
                <forename type="middle">Babu</forename>
                <surname>Somasundaram</surname>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">†</forename>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">Sheeja</forename>
                <surname>Aravindan</surname>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">†</forename>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">Zhongxin</forename>
                <surname>Yu</surname>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">Muralidharan</forename>
                <surname>Jayaraman</surname>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">Ngoc</forename>
                <forename type="middle">T B</forename>
                <surname>Tran</surname>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">Shibo</forename>
                <surname>Li</surname>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">Terence</forename>
                <forename type="middle">S</forename>
                <surname>Herman</surname>
              </persName>
            </author>
            <author>
              <persName>
                <forename type="first">Natarajan</forename>
                <surname>Aravindan</surname>
              </persName>
            </author>
            <title level="a" type="main">Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples</title>
          </analytic>
          <monogr>
            <imprint>
              <date/>
            </imprint>
          </monogr>
          <idno type="DOI">10.1186/s12885-019-5306-0</idno>
          <note>R E S E A R C H A R T I C L E Open Access</note>
        </biblStruct>
      </sourceDesc>
    </fileDesc>
    <profileDesc>
      <abstract>
        <div subtype="dataseer">
          <p>
            <s>Background: MYCN amplification directly correlates with the clinical course of neuroblastoma and poor patient survival, and serves as the most critical negative prognostic marker.</s>
            <s>Although fluorescence in situ hybridization (FISH) remains the gold standard for clinical diagnosis of MYCN status in neuroblastoma, its limitations warrant the identification of rapid, reliable, less technically challenging, and inexpensive alternate approaches.</s>
            <s cert="0.656905472278595" id="dataset-1" type="Tabular data">Methods: In the present study, we examined the concordance of droplet digital PCR (ddPCR, in combination with immunohistochemistry, IHC) with FISH for MYCN detection in a panel of formalin-fixed paraffin-embedded (FFPE) human neuroblastoma samples.</s>
            <s>Results: In 112 neuroblastoma cases, ddPCR analysis demonstrated a 96-100% concordance with FISH.</s>
            <s>Consistently, IHC grading revealed 92-100% concordance with FISH.</s>
            <s>Comparing ddPCR with IHC, we observed a concordance of 95-98%.</s>
            <s cert="0.9814231991767883" id="dataset-2" type="Tabular data">Conclusions: The results demonstrate that MYCN amplification status in NB cases can be assessed with ddPCR, and suggest that ddPCR could be a technically less challenging method of detecting MYCN status in FFPE specimens.</s>
            <s>More importantly, these findings illustrate the concordance between FISH and ddPCR in the detection of MYCN status.</s>
            <s>Together, the results suggest that rapid, less technically demanding, and inexpensive ddPCR in conjunction with IHC could serve as an alternate approach to detect MYCN status in NB cases, with near-identical sensitivity to that of FISH.</s>
          </p>
        </div>
      </abstract>
    </profileDesc>
  </teiHeader>
  <text xml:lang="en">
    <body>
      <div subtype="dataseer">
        <head>Background</head>
        <p>
          <s>Neuroblastoma (NB) is the most common cancer in infants less than one year old (28%) <ref target="#b0" type="bibr">[1,</ref>
            <ref target="#b1" type="bibr">2]</ref> , and accounts for about 6% of all cancers in children <ref target="#b2" type="bibr">[3]</ref> .</s>
          <s>In the United States, the neuroblastoma incidence rate has remained constant at approximately 700 new cases per year <ref target="#b3" type="bibr">[4]</ref> , and heavily contributes to pediatric cancer deaths (9.1%) <ref target="#b2" type="bibr">[3,</ref>
            <ref target="#b4" type="bibr">5,</ref>
            <ref target="#b5" type="bibr">6]</ref> .</s>
          <s>Although significant improvements in overall survival (OS, 40-65%) <ref target="#b4" type="bibr">[5,</ref>
            <ref target="#b5" type="bibr">6]</ref> have been achieved for children with NB in the past thirty years, such OS data mask significant variability in outcomes for different risk groups.</s>
          <s>Although the patients who present with low-risk (stage 1 and 2) NB experience a complete cure, more than half of the patients with high-risk NB will relapse with hematogenous metastasis <ref target="#b6" type="bibr">[7]</ref> , despite intensive multimodal therapy <ref target="#b4" type="bibr">[5,</ref>
            <ref target="#b5" type="bibr">6,</ref>
            <ref target="#b7" type="bibr">[8]</ref>
            <ref target="#b8" type="bibr">[9]</ref>
            <ref target="#b9" type="bibr">[10]</ref>
            <ref target="#b10" type="bibr">[11]</ref>
            <ref target="#b11" type="bibr">[12]</ref>
            <ref target="#b12" type="bibr">[13]</ref>
            <ref target="#b13" type="bibr">[14]</ref>
            <ref target="#b14" type="bibr">[15]</ref> .</s>
          <s>A cure after relapse of progressive disease is extremely rare, with a 5-year OS of &lt; 10% and, 2% long-term survival; compared with 65% in low/intermediate-risk disease (38-71% long-term survival) <ref target="#b4" type="bibr">[5,</ref>
            <ref target="#b5" type="bibr">6,</ref>
            <ref target="#b7" type="bibr">8,</ref>
            <ref target="#b8" type="bibr">9,</ref>
            <ref target="#b10" type="bibr">11,</ref>
            <ref target="#b11" type="bibr">12,</ref>
            <ref target="#b13" type="bibr">14,</ref>
            <ref target="#b15" type="bibr">16]</ref> .</s>
          <s>High-risk disease is typically characterized by several genetic alterations that * Correspondence: naravind@ouhsc.edu</s>
          <s>† Dinesh Babu Somasundaram and Sheeja Aravindan contributed equally to this work.</s>
        </p>
        <p>
          <s>indicate and/or drive poor prognosis for patients with NB, including amplification of the MYCN oncogene.</s>
        </p>
        <p>
          <s>MYCN (V-myc myelocytomatosis viral-related oncogene, neuroblastoma-derived [avian]) is a cellular proto-oncogene of the MYC family of transcription factors.</s>
          <s>MYCN maps to the short arm of chromosome 2 at band 2p24.</s>
          <s>
            <ref target="#b2" type="bibr">3</ref> .</s>
          <s>MYCN amplification encoding the transcription factor N-MYC has been documented in most of the malignant neuroblastomas that cover about 20-25% of all NB <ref target="#b16" type="bibr">[17]</ref> .</s>
          <s>MYCN amplification has also been associated with many chromosomal events, including loss of the distal short arm of 1p, aberration at 11q, and gain of 17q <ref target="#b17" type="bibr">[18]</ref> .</s>
          <s>N-MYC acts as a transcription factor recognizing a consensus sequence (CACGTG) and can activate genes that affect cell growth and differentiation <ref target="#b18" type="bibr">[19]</ref> .</s>
          <s>Thus, MYCN amplification is associated with advanced stage, rapid tumor progression, and poor prognosis <ref target="#b19" type="bibr">[20,</ref>
            <ref target="#b20" type="bibr">21]</ref> .</s>
          <s>Less than 5% of patients with early disease showed MYCN amplification, compared with 30-40% of patients with advanced disease <ref target="#b21" type="bibr">[22]</ref> .</s>
          <s>MYCN amplification values usually range between 50 and 100 fold, although much higher values have been reported.</s>
          <s>Since research has revealed the association of MYCN amplification with NB evolution <ref target="#b22" type="bibr">[23,</ref>
            <ref target="#b23" type="bibr">24]</ref> , independent from disease stage and age at diagnosis, MYCN amplification has been used as the biomarker for risk stratification <ref target="#b16" type="bibr">[17,</ref>
            <ref target="#b24" type="bibr">25,</ref>
            <ref target="#b25" type="bibr">26]</ref> .</s>
          <s>Thus, assessment of MYCN amplification is essential for the diagnostic evaluation of patients with NB <ref target="#b26" type="bibr">[27]</ref> .</s>
          <s cert="0.9926676154136658" id="dataset-3" type="Tabular data">MYCN amplification status in NB must be assessed across all conditions (i.e., new diagnosis, prognosis, prospective and retrospective) and in immediate facilities, without any limitations.</s>
        </p>
        <p>
          <s>Since the original discovery of MYCN amplification in a substantial subset of patients with NB <ref target="#b22" type="bibr">[23]</ref> , a number of methodologies, including southern blotting <ref target="#b27" type="bibr">[28]</ref> , polymerase chain reaction (PCR) <ref target="#b28" type="bibr">[29]</ref> , differential PCR <ref target="#b29" type="bibr">[30]</ref> , quantitative PCR (QPCR) <ref target="#b30" type="bibr">[31]</ref> , fluorescence in situ hybridization (FISH) <ref target="#b31" type="bibr">[32]</ref> /direct FISH <ref target="#b32" type="bibr">[33]</ref> , interphase quantitative FISH (IQ-FISH) <ref target="#b33" type="bibr">[34]</ref> , and chromogenic in situ FISH (CISH) <ref target="#b34" type="bibr">[35]</ref> have been validated as assessment methods.</s>
          <s>In addition, immunohistochemistry (IHC) can be a convenient and cost-effective approach.</s>
          <s>Earlier studies have indicated that N-myc protein expression could serve as one of the most unfavorable prognostic factors in NB patients <ref target="#b35" type="bibr">[36,</ref>
            <ref target="#b36" type="bibr">37]</ref> .</s>
          <s>However, in addition to its technical limitations (e.g., quality of antibody, sensitivity, selectivity), N-myc expression as a stand-alone measure may not always translate to amplification status and could lead to equivocal outcomes.</s>
        </p>
        <p>
          <s>MYCN detection by FISH is widely accepted and currently used in clinical settings.</s>
          <s>With the ability to demonstrate the state of amplification heterogeneity of the tumor cells and the nature of amplification units (double-minute chromosomes or homogeneously stained regions), detection of MYCN amplification with FISH remains a reliable method.</s>
          <s>Despite such benefits, FISH assay is subjective evaluation of images, technically demanding, extremely expensive, and requires good fluorescence scope and technical expertise <ref target="#b37" type="bibr">[38]</ref> .</s>
          <s>Many diagnostic laboratories lack either the expertise or the facilities to perform the test.</s>
          <s>Even in ideal circumstances, the results are often difficult to interpret, requiring the scrutiny of large numbers of individual cells by a highly experienced diagnostician <ref target="#b38" type="bibr">[39]</ref> .</s>
          <s>Also, studies have shown that despite for its high specificity, FISH assay exhibited extremely low (~58%) sensitivity.</s>
          <s>In addition, the technical difficulties in using FFPE specimens for FISH assay (probes ability to penetrate the tissue, high-level of auto-fluorescence, ghost nuclei, loss or weak signals etc.,) and the extremely low sensitivity in FFPE specimens remain the major limitations in using such collections.</s>
          <s>Other limitations are discussed in detail elsewhere <ref target="#b39" type="bibr">[40]</ref> .</s>
          <s>It is important to develop rapid, reliable, and cost-effective alternative strategies to assess MYCN amplification in fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) NB samples.</s>
          <s cert="0.36732780933380127" id="dataset-4" type="Real-Time Polymerase Chain Reaction">Accordingly, we investigated the potential advantages of using highly sensitive Droplet Digital PCR (ddPCR) <ref target="#b40" type="bibr">[41]</ref> technology in conjunction with qualitative IHC to detect MYCN amplification in fresh, frozen, and FFPE NB samples, and compared it with the current standard of detection, FISH.</s>
        </p>
      </div>
      <div subtype="dataseer">
        <head>Methods</head>
        <p>
          <s cert="0.9758289456367493" id="dataset-5" type="Tabular data">We examined specimens from 116 cases of human NB.</s>
          <s cert="0.9915875792503357" id="dataset-6" type="Tabular data">Specimens were collected from our institutional (University of Oklahoma Health Sciences, OUHSC) pediatrics pathology collection (82 specimens), the Oregon Health and Science University Biospecimen core (24 specimens) and the NIH-NCI Cooperative Human Tissue Network (CHTN, 10 specimens).</s>
          <s>All protocols were approved by the University of Oklahoma Health Sciences Center Institutional Review Board with permission for the research use of de-identified specimens.</s>
          <s>All experiments were performed in accordance with the University of Oklahoma Health Sciences Institutional Review Board guidelines and regulations for the protection of human subjects.</s>
          <s cert="0.9471169114112854" id="dataset-7" type="Tabular data">Hematoxylin-eosin stained sections were examined by a pediatric pathologist.</s>
          <s id="dataset-1" type="Tabular data:Subject Data Table">Only cases with sufficient percent tumor (and minimal necrosis) and adequate tumor volume for multiple assays were included.</s>
          <s>On this basis, four specimens were excluded.</s>
          <s>The results were computed for a total of 112 samples, of which 79 specimens had known MYCN status, as assessed in clinics using FISH analysis.</s>
        </p>
      </div>
      <div subtype="dataseer">
        <head>MYCN amplification detection by FISH</head>
        <p>
          <s>For FISH analysis, the tumor region in 4-μm-thick FFPE sections was selected by the pathologist.</s>
          <s>For MYCN amplification, Kreatech™ MYCN (2p24) / AFF3 (2q11) FISH probe (Leica Biosystems Inc., Buffalo Grove, IL, USA) was used.</s>
          <s>MYCN Amplification at region 2p24 will show several red signals compared with the control AFF3 (2q11) region, which will provide two signals <ref target="#fig_0" type="figure">(Fig. 1</ref> ).</s>
          <s cert="0.9695286154747009" id="dataset-8" type="Tabular data">FISH assays were performed in the Cytogenetic Molecular division of the OUHSC Pediatrics Clinical Genetics Core and in the Tissue Pathology Core of the Stephenson Cancer Center, following standard protocols.</s>
          <s id="dataset-2" type="Tabular data:Assay">Ten specimens, including four with known MYCN status (two amplified and two non-amplified; for assay controls) and six with unknown status were independently assayed in the two facilities.</s>
          <s>The FISH signals were independently evaluated by two investigators (NA, DS) and validated by a pediatric pathologist (ZY).</s>
        </p>
      </div>
      <div subtype="dataseer">
        <head>N-myc expression detection by IHC</head>
        <p>
          <s cert="0.9734557867050171" id="dataset-9" type="Tabular data">All tissue section processing and immunohistochemistry (IHC) was performed in the Tissue Pathology Core of the Stephenson Cancer Center, as described in our earlier studies <ref target="#b41" type="bibr">[42]</ref>
            <ref target="#b42" type="bibr">[43]</ref>
            <ref target="#b43" type="bibr">[44]</ref> .</s>
          <s>Mouse monoclonal N-myc antibody raised against human N-myc mapping to 2p24.3 (Santa Cruz Biotechnology Inc., Dallas, TX) was used.</s>
          <s cert="0.9369082450866699" id="dataset-10" type="Image">N-myc IHC was performed utilizing an automated IHC machine (Leica Bond III), according to the manufacturer's protocol, using the Bond™ Polymer Refine detection system.</s>
          <s>A peroxidase-diaminobenxidine visualization process, which gave positive immunoreactivity a brown color, was employed.</s>
          <s cert="0.956419050693512" id="dataset-11" type="Tabular data">Appropriate tissue histology controls stained with hematoxylin-eosin stain and negative controls with no primary antibody were examined in parallel.</s>
          <s cert="0.7215015888214111" id="dataset-12" type="Image">The slides were digitally scanned into virtual slides using an Aperio Scan Scope (Aperio Technologies, Inc., Buffalo Grove, IL, USA) slide scanner at 20x magnification.</s>
          <s cert="0.6663063764572144" id="dataset-13" type="Image">The whole slide images were then group-analyzed for N-myc -specific positivity using Aperio image analysis and quantification software (Aperial Tool Box) with the appropriate algorithms for IHC.</s>
          <s>Automated strong nuclear positivity was quantified and the metadata were exported to Excel.</s>
          <s>N-myc expression was independently graded by two pathologists (ZY, NTT) who were blinded to FISH and ddPCR status.</s>
          <s>Scores for N-myc immunoreactivity in IHC staining were graded on a scale of 0-3 (0 = negative, 1 = weak, 2 = moderate, 3 = strong; <ref target="#fig_1" type="figure">Fig. 2</ref> ).</s>
          <s>For inter-assay crisscross analysis, IHC grading results were further computed to fit the criteria, true positive vs. true negative expression.</s>
          <s>For this, grading scales of 2 and 3 are regarded as 'positive' and scale 1 and 0 as 'negative'.</s>
        </p>
      </div>
      <div subtype="dataseer">
        <head>MYCN amplification by ddPCR</head>
        <p>
          <s>For DNA isolation, ten 6-μM-thick sections were cut from each FFPE block and were collected in DNAse-free sterile microcentrifuge tubes.</s>
          <s>Genomic DNA was extracted using a HighPrep™ FFPE Tissue DNA Kit (Mag-Bio, Gaithersburg, MD) according to the manufacturer's protocol.</s>
          <s>The quality and the quantity of the isolated DNA were determined using our routine laboratory protocols <ref target="#b44" type="bibr">[45]</ref> .</s>
          <s cert="0.7392295002937317" id="dataset-3" type="Genetic Data:Genotype">MYCN copy number variations were assessed using TaqMan Copy Number (Hs00658058_cn, ThermoFisher Scientific, Waltham, MA) assay.</s>
          <s>RNaseP (4,403,326, ThermoFisher) assay was used for reference gene.</s>
          <s>For ddPCR, the HINDIII-digested DNA (5 ng) was subjected to PCR (final reaction volume of 20 μL) utilizing ddPCR™ Supermix for probes (BioRad, Hercules, To generate droplets, individual reaction mixtures were then loaded into a DG8 cartridge (Bio-Rad) with 70 μL of droplet generation oil.</s>
          <s>The droplets from each well were transferred into a 96-well PCR plate, heat-sealed, and subjected to PCR: 95°C for 10 min, followed by 40 cycles of 94°C for 30 s, 60°C for 1 min, and 98°C for 10 min.</s>
          <s cert="0.8740618824958801" id="dataset-4" type="Genetic Data:Digital Droplet PCR">The droplets of each well were then analyzed in a QX100 droplet reader (Bio-Rad) and were quantified using target DNA.</s>
          <s>The outcome data were analyzed using QuantaSoft version 1.7.4.0917 (Bio-Rad), and the copy number variation was determined <ref type="figure">(Fig. 3)</ref> .</s>
        </p>
      </div>
      <div>
        <head>Statistical analysis</head>
        <p>
          <s>All statistical analyses and graph plots were performed using GraphPad Prism software.</s>
          <s>Correlations between each assay were evaluated using nonlinear regression analysis, and the goodness of fit was calculated.</s>
          <s>Nonlinear regression analysis fits our model, which offers more options such as, the ability to compare two models (ddPCR vs FISH; ddPCR vs IHC; IHC vs FISH), apply weighting, automatically exclude outliers and perform normality tests on the residuals.</s>
          <s>In this study, for specimens with known FISH status (n = 79) the goodness of fit was calculated independently for ddPCR or IHC against FISH data.</s>
          <s>For the specimens with unknown FISH status (n = 33) the goodness of fit was calculated independently for ddPCR and FISH against IHC data.</s>
          <s>In each case, the quantification of the goodness-of-fit was presented as R square.</s>
        </p>
      </div>
      <div>
        <head>Results</head>
        <p>
          <s>Seventy-nine specimens had known MYCN status per FISH analyses (n = 14, MYCN-amplified; n = 65, non-amplified).</s>
          <s>In these 79 specimens with known MYCN status, ddPCR demonstrated MYCN amplification in 11 specimens and no amplification in 68 specimens <ref target="#fig_0" type="figure">(Table 1, Fig. 4)</ref> .</s>
          <s>Compared with FISH data, ddPCR results had 79% concordance <ref type="bibr">(11/14)</ref> for amplified samples and 100% concordance (65/ 65) for non-amplified samples <ref target="#fig_0" type="figure">(Table 1, Fig. 4)</ref> .</s>
          <s>Computing together the amplified and non-amplified cases, ddPCR results showed outstanding agreement (96.2% concordance and 3.8% discordance) with the FISH analysis <ref target="#tab_1" type="table">(Table 1)</ref>
            <ref target="#fig_2" type="figure">Fig. 4)</ref> .</s>
          <s>Overall, IHC results showed excellent agreement (91.2% concordance) with FISH.</s>
          <s>More importantly, comparative analysis between ddPCR and IHC data analysis revealed 100% concordance for MYCN-amplified cases <ref target="#fig_0" type="figure">(Table 1, Fig. 4)</ref> .</s>
          <s>Conversely, we observed a concordance of about 94.1% (64/68) for non-amplified cases with ddPCR results <ref target="#tab_1" type="table">(Table 1)</ref> .</s>
          <s>For all 79 cases, there was a 94.9% concordance between ddPCR and IHC.</s>
          <s>Together, the ddPCR results coupled with IHC data corroborated with the known FISH status and strongly suggest that ddPCR and IHC could serve as an alternative to FISH, particularly for FFPE specimens.</s>
          <s>To substantiate the benefits of using ddPCR in conjunction with IHC for MYCN amplification detection, we investigated the feasibility of assessment in a cohort of 33 NB cases with unknown MYCN status.</s>
          <s>First, as a fail-proof measure, we performed FISH on 10 cases, four with known MYCN status (two amplified and two non-amplified) and six from the cohort of unknown status.</s>
          <s>Since it is extremely challenging to perform FISH in FFPE sections, particularly in stored sections, and often produced equivocal results, two independent core facilities performed FISH with the same set of slides.</s>
          <s>The FISH analysis for the cases with known status yielded consistent results from both facilities, and served as the positive and negative controls for the assay <ref target="#fig_0" type="figure">(Fig. 1)</ref> .</s>
          <s>Of the six cases with unknown status, FISH analysis revealed MYCN amplification in one specimen and no amplification in the remaining 5 specimens.</s>
          <s>ddPCR analysis of all 33 cases showed three cases with MYCN amplification and 30 cases without amplification <ref target="#fig_3" type="figure">(Fig. 5</ref> ).</s>
          <s>In addition, IHC grading analysis revealed positive expression of N-myc in four cases and negative expression in 29 cases.</s>
          <s>Compared with ddPCR data, IHC had 96.7% concordance (29/30) for non-amplified samples and 100% concordance (3/3) for amplified cases ( <ref target="#tab_2" type="table">Table 2</ref> , <ref target="#fig_3" type="figure">Fig. 5</ref> ).</s>
          <s>More importantly, comparative analysis between all three assay platforms demonstrated perfect concordance (100%) of FISH results with both the ddPCR and IHC analysis <ref target="#fig_1" type="figure">(Table 2, Fig. 5</ref> ).</s>
        </p>
      </div>
      <div>
        <head>Discussion</head>
        <p>
          <s>Digital droplet PCR is a promising platform for high throughput assessment and quantitation of the targeted copy number variation.</s>
          <s>In this study, we demonstrate that the ddPCR platform is comparable to traditional FISH method for MYCN gene amplification in NB.</s>
          <s>In about 20-25% of neuroblastomas, poor prognosis has been directly correlated with MYCN oncogene <ref target="#b45" type="bibr">[46]</ref> amplification, which has been shown to orchestrate rapid progression and therapy resistance <ref target="#b19" type="bibr">[20,</ref>
            <ref target="#b46" type="bibr">[47]</ref>
            <ref target="#b47" type="bibr">[48]</ref>
            <ref target="#b48" type="bibr">[49]</ref> .</s>
          <s>Since MYCN amplification is directly correlated with aggressive clinical course of NB and poor patient survival, it has been recognized as the most critical negative prognostic marker.</s>
          <s>To that end, MYCN amplification status currently guides the therapeutic strategy in children with otherwise favorable prognostic indicators <ref target="#b49" type="bibr">[50]</ref> .</s>
          <s>Due to its significance, reliable laboratory data for evaluating MYCN status are essential.</s>
          <s>Currently, FISH analysis (MYCN status at the level of DNA) and IHC (protein expression) are used in clinical diagnosis.</s>
          <s>Although IHC is easy to perform, rapid, and relatively cost-effective, limitations, including the sensitivity, specificity and functional relevance, indicate that IHC should be considered only as a secondary and/or confirmatory approach.</s>
          <s>To date, FISH analysis remains the gold standard for assessing MYCN amplification status in NB.</s>
          <s>However, it is technically demanding, very expensive, and requires specific equipment and expertise <ref target="#b37" type="bibr">[38,</ref>
            <ref target="#b38" type="bibr">39]</ref> .</s>
          <s>Moreover, it is highly challenging to perform FISH assays in FFPE sections.</s>
          <s>Such limitations <ref target="#b39" type="bibr">[40]</ref> highlight the need for the development and use of less expensive, less technically demanding, easily accessible, and rapid methods for MYCN detection in NB that could produce near-identical sensitivity to that of FISH.</s>
        </p>
        <p>
          <s>The results presented here show that detection of MYCN amplification by ddPCR will fill this gap with 96-100% concordance and could serve as an alternative to FISH analysis.</s>
          <s>However, the present study did not compare the sensitivity and specificity of FISH and ddPCR protocols in the NB setting.</s>
          <s>The results presented here, for the first time, demonstrate that ddPCR in conjunction with IHC grading could serve as an alternative to detect MYCN amplification status in NB specimens.</s>
          <s>Our experience in detecting MYCN using FFPE specimens clearly shows that ddPCR is less challenging than FISH analysis.</s>
          <s>ddPCR has been adopted in the determination of copy number variation an array of tumor systems, including breast cancer <ref target="#b50" type="bibr">[51]</ref> , gastric cancer <ref target="#b51" type="bibr">[52]</ref> , and lung cancer <ref target="#b52" type="bibr">[53]</ref> .</s>
          <s>Researchers have reported the benefit of using ddPCR in FFPE specimens <ref target="#b53" type="bibr">[54,</ref>
            <ref target="#b54" type="bibr">55]</ref> .</s>
          <s>The results of the present study, for the first time, indicated the potential use of ddPCR in the detection of MYCN amplification status in NB cases and further recognized the reliability and feasibility of ddPCR in determining MYCN status from FFPE specimens.</s>
          <s>High-throughput ddPCR yields absolute quantitation of DNA copy number with an immediate utility to determine copy number variation and detect rare alleles and circulating DNA.</s>
          <s>Compared with FISH, ddPCR offers high-throughput analysis with simple workflow <ref target="#b55" type="bibr">[56]</ref> , and is cost-effective (~$30/rxn vs. a minimum of $300 for FISH).</s>
          <s>Moreover, ddPCR is highly sensitive, provides absolute copy number variation, utilizes low DNA concentration, allows absolute quantitation, and is a rapid process (8-10 h/16 samples from DNA-isolation to ddPCR readout vs. days for FISH).</s>
          <s>ddPCR sample analysis time frame could be extrapolated for 96 samples with added time for additional sample DNA isolation.</s>
          <s>Also, ddPCR analysis demands basic technical expertise compared to FISH assay that requires scrutiny of large numbers of individual cells by a highly experienced diagnostician.</s>
          <s>Further, the technical difficulties (probes ability to penetrate the tissue, high-level of auto-fluorescence, ghost nuclei, loss or weak signals etc.,) in FISH for handling FFPE specimens are entirely eluded in ddPCR (directly utilize DNA) and hence offers relatively high sensitivity.</s>
          <s>Although the FISH to ddPCR discordance rate observed here was negligible (0-5%), many factors could be responsible and should be considered limitations for ddPCR.</s>
          <s>These factors include the variability in the quality of DNA extracted from FFPE samples, availability of tumor tissues in the sections, tumor to necrosis ratio, and technical issues in droplet generation.</s>
          <s>To that end, ddPCR includes a multi-step (requirement to generate droplets) procedure and the specific target is limited.</s>
          <s>Furthermore, this study did not include the microdissection method to obtain cancer cells from the FFPE samples for ddPCR processing.</s>
          <s>Despite, this method is highly efficient as it enables objective evaluation with the provision of numerical values when compared to conventional methods that depend on the subjective evaluation of images.</s>
          <s>In addition to the limitations of ddPCR discussed above, authors acknowledge that ddPCR requires designated space to minimize the risk of contamination that could limit its adoption in some clinical environments.</s>
          <s>Also on a minor note, at least in the present study, ddPCR utilizes relatively more tissue (10 × 6 μM sections) while for FISH analysis only two 4 μM sections is used.</s>
          <s>However owing to its advantages ddPCR platform could serve as a promising alternative for the conventional methods.</s>
          <s>Also, ddPCR platform will be highly useful for retrospective studies that involve analysis of samples in hundreds.</s>
        </p>
        <p>
          <s>Studies have clearly affirmed that N-myc protein expression could serve as one of the most unfavorable prognostic factors in NB patients <ref target="#b35" type="bibr">[36,</ref>
            <ref target="#b36" type="bibr">37]</ref> .</s>
          <s>However, the discordance between FISH and IHC or ddPCR and IHC could be attributable to factors including variability in tissue fixation/processing, variable sensitivity/specificity of commercially available antibodies, variations in grading criteria and inter-observer variability in data interpretation <ref target="#b56" type="bibr">[57]</ref> .</s>
          <s>Furthermore, IHC measures the amount of accumulated N-myc protein that could greatly depend on the transcriptional and post-transcriptional mechanisms existing in some tumors.</s>
          <s>The results presented in this study affirms the prognostic significance of N-myc expression and aligns with the earlier COG study <ref target="#b36" type="bibr">[37]</ref> .</s>
          <s>To that end, the claim is that N-myc expression with IHC could serve as an additional validation to define MYCN status when used in conjunction with ddPCR.</s>
        </p>
        <p>
          <s>In conclusion, the results of the present study showed that MYCN amplification status in NB cases could be assessed by relatively cost-effective, rapid, feasible, and reliable high-throughput ddPCR.</s>
          <s>Further, the results indicated that ddPCR could serve as a less technically challenging method to detect MYCN status in FFPE NB specimens.</s>
          <s>These findings revealed the concordance between FISH and ddPCR analyses in the detection of MYCN amplification status in FFPE NB specimens.</s>
          <s>Overall, the results presented here suggest that ddPCR, in conjunction with IHC, could serve as an alternate approach to detect MYCN status in NB cases, with near-identical sensitivity to FISH.</s>
          <s>This approach is highly beneficial in two settings (i) in places where there is a shortage of expertise, instrumentation and funds to use FISH and (ii) when there is a retrospective study involving hundreds and thousands of cases to investigate.</s>
          <s>Furthermore, the ddPCR approach has significant advantage over FISH for the FFPE specimens.</s>
          <s>Availability of data and materials All data generated or analyzed during this study are included in this published article.</s>
        </p>
        <p>
          <s>Authors' contributions DS performed FFPE DNA isolation and ddPCR experiments and data analysis.</s>
          <s>SA performed IHC staining and FISH experiments and data analysis.</s>
          <s>ZY performed selection and screening of specimens, microphotography and IHC grading analysis.</s>
          <s>MJ contributed to ddPCR reagents/analytical tools, assisted with ddPCR data analysis and interpretation.</s>
          <s>NT performed microphotography, IHC grading and data analysis.</s>
          <s>SL Performed FISH experiments TH contributed reagents/analytical tools, assisted with data interpretation, and critically read the manuscript.</s>
          <s>NA conceived the project, designed the experiments, performed data analysis and interpretation, and wrote the manuscript.</s>
          <s>All authors read and approved the final manuscript.</s>
        </p>
        <p>
          <s>Ethics approval and consent to participate All protocols were approved by the University of Oklahoma Health Sciences Center Institutional Review Board with permission for the research use of deidentified specimens (OUHSC IRB #6207).</s>
          <s>All experiments were performed in accordance with the University of Oklahoma Health Sciences Institutional Review Board guidelines and regulations for the protection of human subjects.</s>
        </p>
      </div>
      <div>
        <head>Consent for publication</head>
        <p>
          <s>Not Applicable.</s>
        </p>
      </div>
      <div>
        <head>Competing interests</head>
        <p>
          <s>The authors declare that they have no competing interests.</s>
        </p>
      </div>
      <figure xml:id="fig_0">
        <head>Fig. 1</head>
        <label>1</label>
        <figDesc>Fluorescence in situ hybridization (FISH) for MYCN amplification in human NB specimens. Representative microphotographs of MYCN FISH analysis showing (a) negative amplification (non-amplified) of human MYCN gene with the ratio of MYCN (red signals, indicated by yellow arrowheads) to AFF3 (green signals, indicated by white arrowheads) obviously 1 (2R2G), (b) positive amplification of human MYCN gene with amplified signal of 2 + R2G, and (c) positive MYCN amplification signal appearing as a homogenously stained region and/or double minutes containing numerous signals CA).</figDesc>
      </figure>
      <figure xml:id="fig_1">
        <head>Fig. 2</head>
        <label>2</label>
        <figDesc>Immunohistochemistry for MYCN protein expression in human neuroblastomas. Representative microphotographs of MYCN IHC staining showing (a) completely negative (IHC0), (b) weak/faint nuclear positivity (IHC1+), (c) moderate nuclear positivity (IHC2+), and, (d) strong nuclear immunoreactivity (IHC3+) in FFPE sections from NB cases. Insert: Representative staining patterns shown in 40x magnification</figDesc>
      </figure>
      <figure xml:id="fig_2">
        <head>Fig. 4</head>
        <label>4</label>
        <figDesc>Comparison of ddPCR and IHC MYCN results with FISH data from the FFPE tissue samples from 79 neuroblastoma cases. Interleaved scatter-plot showing concordance (and discordance) in MYCN amplification status assessment by ddPCR and IHC compared with FISH analysis. A total of 79 neuroblastoma cases with known MYCN status (14 amplified and 65 non-amplified) assessed by FISH as a part of clinical diagnosis were included in the analysis</figDesc>
      </figure>
      <figure xml:id="fig_3">
        <head>Fig. 5</head>
        <label>5</label>
        <figDesc>Inter-comparison of MYCN amplification status data from ddPCR, IHC, and FISH analyses of FFPE tissue samples from 33 NB cases. Interleaved scatter-plot showing concordance (and discordance) levels in MYCN amplification status measures between ddPCR, IHC, and FISH analyses. A total of 33 neuroblastoma cases with unknown MYCN status were included in the analysis. FISH was performed on 10 cases, four with known MYCN status (two amplified and two non-amplified) and six from the cohort of unknown status</figDesc>
      </figure>
      <figure xml:id="fig_4">
        <head/>
        <label/>
        <figDesc>Abbreviations CISH: Chromogenic in situ FISH; ddPCR: Droplet Digital PCR; FFPE: Formalinfixed, paraffin-embedded; FISH: Fluorescence in situ hybridization; IHC: Immunohistochemistry; IQ-FISH: Interphase quantitative FISH; MYCN: Vmyc myelocytomatosis viral-related oncogene, neuroblastoma-derived [avian]; NB: Neuroblastoma; N-myc: Proto-oncogene protein, basic helix-loophelix protein 37 (bHLHe37), protein encoded by the MYCN gene.; OS: Overall survival; PCR: Polymerase chain reaction; QPCR: Quantitative PCR men pathology core, and OUHSC Pediatrics Clinical Genetics Core -Cytogenetic Molecular division for their services. The authors also acknowledge the OUHSC Staff Editor (Ms. Kathy Kyler) for the help in critically reviewing this manuscript. Funding The authors are supported by research funding from the National Institutes of Health (NIH 1P20GM103639-01) Centers of Biomedical Research Excellence (COBRE) Program and the University of Oklahoma Health Sciences Center (OUHSC) Department of Radiation Oncology Research Development Funds.</figDesc>
      </figure>
      <figure type="table" validated="false" xml:id="tab_0">
        <head/>
        <label/>
        <figDesc>. Conversely, N-myc IHC coupled with pathologists' grading revealed N-myc expression in 15 specimens and no expression in 64 specimens. Compared with FISH data, MYCN IHC results had concordance of 73% (11/15) for positive N-myc expression and 95.3% (61/64) concordance for negative N-myc expression (Table 1,</figDesc>
        <table/>
      </figure>
      <figure type="table" validated="false" xml:id="tab_1">
        <head>Table 1</head>
        <label>1</label>
        <figDesc>Inter-assay concordance analysis of human MYCN status determined by ddPCR, IHC (N-myc) and FISH in human neuroblastoma A total of 79 selected cases with known MYCN status (14 amplified and 65 non-amplified) assessed by FISH as a part of clinical diagnosis were included in the analysis. Number of cases and percent measures of concordance in FISH vs ddPCR, IHC vs. FISH, and ddPCR vs. IHC are presented for amplified and non-amplified cases</figDesc>
        <table>DD-PCR 
FISH Amplified 
FISH Non-amplified 
Concordance by DDPCR 
Discordance by DDPCR 

Non-amplified (n = 68) 
3 
65 
(65/65)100% 
(0/65)0% 

Amplified (n = 11) 
11 
0 
(11/14)79% 
(3/14)21% 

IHC 
FISH Amplified 
FISH Non-amplified 
Concordance by IHC 
Discordance by IHC 

Negative (n = 64) 
3 
61 
(61/64)95.3% 
(3/64)4.7% 

Positive (n = 15) 
11 
4 
(11/15)73% 
(4/15)27% 

DD-PCR 
IHC Positive 
IHC Negative 
Concordance by DDPCR 
Discordance by DDPCR 

Non-amplified (n = 68) 
4 
64 
(64/68)94.1% 
(4/68)5.9% 

Amplified (n = 11) 
11 
0 
(11/11)100% 
(0/11)0% 

a 

b 

c 

Fig. 3 Analysis of MYCN amplification by droplet digital PCR in human NB specimens. Representative one dimensional ddPCR plots for (a) MYCN 
and (b) reference gene RNAseP showing side-by-side comparison of MYCN copy number variations in MYCN amplified and non-amplified NB 
cases. MYCN was read in blue (FAM) channel, while RNASeP was read in green (HEX) channel. Each point represents a single droplet, which is 
scored as positive (colored and above the threshold intensity, as indicated by the pink line) or negative (grey, below the threshold line), 
depending on the fluorescent amplitude. (c) Representative (from amplified and non-amplified cases) two-dimensional scatter plots constructed 
with overlaid ddPCR data of the reference RNAseP (HEX) and MYCN (FAM) showing droplets containing no template (lower left, black), droplets 
containing only MYCN template (upper left, blue), droplets containing only reference RNAseP template (lower right, green), and droplets 
containing both MYCN and RNAseP templates (upper right, brown) 
</table>
      </figure>
      <figure type="table" validated="true" xml:id="tab_2">
        <head>Table 2</head>
        <label>2</label>
        <figDesc>Inter-assay concordance analysis of human MYCN status determined by ddPCR and IHC (N-myc) in human NB</figDesc>
        <table>DD-PCR 
IHC Positive 
IHC Negative 
Concordance by DDPCR 
Discordance by DDPCR 

Non-amplified (n = 30) 
1 
29 
(29/30)96.7% 
(1/30)3.3% 

Amplified (n = 3) 
3 
0 
(3/3)100% 
(0/3)0% 

A total of 33 blinded cases with unknown MYCN status were included in the analysis. Number of cases and percent measures of concordance in ddPCR vs. IHC 
is presented for amplified and non-amplified cases 
</table>
      </figure>
    </body>
    <back>
      <div type="acknowledgement">
        <div>
          <head>Acknowledgements</head>
          <p>
            <s>The authors acknowledge the neuroblastoma specimen providers: Department of Pathology, University of Oklahoma Health Sciences Center; Cooperative Human Tissue Network (CHTN), which is funded by the National Cancer Institute (NCI), and; Oregon Health and Science University Biospecimen core.</s>
            <s>The authors acknowledge the Stephenson Cancer Center (SCC) -COBRE Histochemistry and immunology core, SCC-COBRE Biospeci-</s>
          </p>
        </div>
      </div>
      <div type="annex">
        <div>
          <p>
            <s>Anesthesiology, University of Oklahoma Health Sciences Center, 920 SL Young Blvd #1140, Oklahoma City, OK 73104-5036, USA.</s>
          </p>
          <p>
            <s>Received: 13 December 2017 Accepted: 16 January 2019</s>
          </p>
        </div>
      </div>
      <div type="references">
        <listBibl>
          <biblStruct xml:id="b0">
            <analytic>
              <title level="a" type="main">Sympathetic nervous system tumors. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute</title>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">G</forename>
                  <surname>Marc</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">G</forename>
                  <surname>Gurney</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">A</forename>
                  <surname>Smith</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">F</forename>
                  <surname>Olshan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Bethesda</title>
              <imprint>
                <biblScope from="65" to="72" unit="page"/>
                <date type="published" when="1999"/>
                <publisher>NIH Pub</publisher>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b1">
            <monogr>
              <title level="m" type="main">Cancer among infants. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda: National Cancer Institute</title>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">G</forename>
                  <surname>Gurney</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">A</forename>
                  <surname>Smith</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">A</forename>
                  <surname>Ross</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="1999"/>
                <publisher>NIH Pub</publisher>
                <biblScope from="149" to="56" unit="page"/>
              </imprint>
            </monogr>
            <note>XII</note>
          </biblStruct>
          <biblStruct xml:id="b2">
            <analytic/>
            <monogr>
              <title level="m">Society AC: Cancer Facts &amp; Figures</title>
              <imprint>
                <publisher>American Cancer Society</publisher>
                <date type="published" when="2017"/>
                <biblScope unit="volume">2017</biblScope>
                <biblScope from="1" to="56" unit="page"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b3">
            <analytic>
              <title level="a" type="main">SEER data submission: National Cancer Institute</title>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Howlader</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Noone</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Krapcho</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Neyman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Aminou</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <surname>Waldron</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Altekruse</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Kosary</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Ruhl</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <surname>Tatalovich</surname>
                </persName>
              </author>
              <ptr target="https://seer.cancer.gov/archive/csr/1975_2009_pops09"/>
            </analytic>
            <monogr>
              <title level="j">Cancer Statistics Review</title>
              <imprint>
                <biblScope from="1975" to="2009" unit="page"/>
                <date type="published" when="2009-11"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b4">
            <analytic>
              <title level="a" type="main">Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">A</forename>
                  <surname>Morgenstern</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Baruchel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">S</forename>
                  <surname>Irwin</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Pediatr Hematol Oncol</title>
              <imprint>
                <biblScope unit="volume">35</biblScope>
                <biblScope unit="issue">5</biblScope>
                <biblScope from="337" to="384" unit="page"/>
                <date type="published" when="2013"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b5">
            <analytic>
              <title level="a" type="main">Outcomes for children and adolescents with cancer: challenges for the twenty-first century</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">A</forename>
                  <surname>Smith</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <forename type="middle">L</forename>
                  <surname>Seibel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">F</forename>
                  <surname>Altekruse</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">A</forename>
                  <surname>Ries</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">L</forename>
                  <surname>Melbert</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>O&amp;apos;leary</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <forename type="middle">O</forename>
                  <surname>Smith</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">H</forename>
                  <surname>Reaman</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Clin Oncol</title>
              <imprint>
                <biblScope unit="volume">28</biblScope>
                <biblScope unit="issue">15</biblScope>
                <biblScope from="2625" to="2659" unit="page"/>
                <date type="published" when="2010"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b6">
            <analytic>
              <title/>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Maris</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">D</forename>
                  <surname>Hogarty</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Bagatell</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">L</forename>
                  <surname>Cohn</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <surname>Neuroblastoma</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Lancet</title>
              <imprint>
                <biblScope unit="volume">369</biblScope>
                <biblScope unit="issue">9579</biblScope>
                <biblScope from="2106" to="2126" unit="page"/>
                <date type="published" when="2007"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b7">
            <analytic>
              <title level="a" type="main">Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study</title>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">K</forename>
                  <surname>Matthay</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">P</forename>
                  <surname>Reynolds</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">C</forename>
                  <surname>Seeger</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Shimada</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <forename type="middle">S</forename>
                  <surname>Adkins</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Haas-Kogan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">B</forename>
                  <surname>Gerbing</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">B</forename>
                  <surname>London</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">G</forename>
                  <surname>Villablanca</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Clin Oncol</title>
              <imprint>
                <biblScope unit="volume">27</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="1007" to="1020" unit="page"/>
                <date type="published" when="2009"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b8">
            <analytic>
              <title level="a" type="main">New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcome</title>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">A</forename>
                  <surname>Cole</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Maris</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Clin Cancer Res</title>
              <imprint>
                <biblScope unit="volume">18</biblScope>
                <biblScope unit="issue">9</biblScope>
                <biblScope from="2423" to="2431" unit="page"/>
                <date type="published" when="2012"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b9">
            <analytic>
              <title level="a" type="main">Disease control intervals in high-risk neuroblastoma</title>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <forename type="middle">M</forename>
                  <surname>Santana</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">L</forename>
                  <surname>Furman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">M</forename>
                  <surname>Mcgregor</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">A</forename>
                  <surname>Billups</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Cancer</title>
              <imprint>
                <biblScope unit="volume">112</biblScope>
                <biblScope unit="issue">12</biblScope>
                <biblScope from="2796" to="801" unit="page"/>
                <date type="published" when="2008"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b10">
            <analytic>
              <title level="a" type="main">Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials</title>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Simon</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Berthold</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Borkhardt</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Kremens</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">De</forename>
                  <surname>Carolis</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Hero</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Pediatr Blood Cancer</title>
              <imprint>
                <biblScope unit="volume">56</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="578" to="83" unit="page"/>
                <date type="published" when="2011"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b11">
            <analytic>
              <title level="a" type="main">Factors influencing survival in children with recurrent neuroblastoma</title>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Lau</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Tai</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Weitzman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Grant</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Baruchel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Malkin</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Pediatr Hematol Oncol</title>
              <imprint>
                <biblScope unit="volume">26</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="227" to="259" unit="page"/>
                <date type="published" when="2004"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b12">
            <analytic>
              <title level="a" type="main">The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients</title>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Berthold</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Hero</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Breu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Christiansen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Erttmann</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Gnekow</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Herrmann</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Klingebiel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Lampert</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Muller-Weihrich</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Ann Oncol</title>
              <imprint>
                <biblScope unit="volume">7</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="183" to="190" unit="page"/>
                <date type="published" when="1996"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b13">
            <analytic>
              <title level="a" type="main">Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry</title>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Garaventa</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Parodi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">De</forename>
                  <surname>Bernardi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Dau</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Manzitti</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Conte</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Casale</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Viscardi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Bianchi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D&amp;apos;</forename>
                  <surname>Angelo</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Eur J Cancer</title>
              <imprint>
                <biblScope unit="volume">45</biblScope>
                <biblScope unit="issue">16</biblScope>
                <biblScope from="2835" to="2877" unit="page"/>
                <date type="published" when="2009"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b14">
            <analytic>
              <title level="a" type="main">Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma</title>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Weiss</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Vora</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Huberty</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">A</forename>
                  <surname>Hawkins</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">K</forename>
                  <surname>Matthay</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Pediatr Hematol Oncol</title>
              <imprint>
                <biblScope unit="volume">25</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="543" to="550" unit="page"/>
                <date type="published" when="2003"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b15">
            <analytic>
              <title level="a" type="main">Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the international neuroblastoma risk group project</title>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">B</forename>
                  <surname>London</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Castel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Monclair</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <forename type="middle">F</forename>
                  <surname>Ambros</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">D</forename>
                  <surname>Pearson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">L</forename>
                  <surname>Cohn</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Berthold</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Nakagawara</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">L</forename>
                  <surname>Ladenstein</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Iehara</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Clin Oncol</title>
              <imprint>
                <biblScope unit="volume">29</biblScope>
                <biblScope unit="issue">24</biblScope>
                <biblScope from="3286" to="92" unit="page"/>
                <date type="published" when="2011"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b16">
            <analytic>
              <title/>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">K</forename>
                  <surname>Matthay</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Maris</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Schleiermacher</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Nakagawara</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">L</forename>
                  <surname>Mackall</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Diller</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">A</forename>
                  <surname>Weiss</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <surname>Neuroblastoma</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Nat Rev Dis Primers</title>
              <imprint>
                <biblScope unit="volume">2</biblScope>
                <biblScope unit="page">16078</biblScope>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b17">
            <analytic>
              <title level="a" type="main">Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: a report from the international neuroblastoma risk group project</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Thompson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">T</forename>
                  <surname>Vo</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">B</forename>
                  <surname>London</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Fischer</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <forename type="middle">F</forename>
                  <surname>Ambros</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Nakagawara</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">M</forename>
                  <surname>Brodeur</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">K</forename>
                  <surname>Matthay</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">G</forename>
                  <surname>Dubois</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Cancer</title>
              <imprint>
                <biblScope unit="volume">122</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="935" to="980" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b18">
            <monogr>
              <title level="m" type="main">Neuroblastoma and MYCN. Cold Spring Harbor perspectives in medicine</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Huang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">A</forename>
                  <surname>Weiss</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="2013"/>
                <biblScope unit="volume">3</biblScope>
                <biblScope unit="page">14415</biblScope>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b19">
            <analytic>
              <title level="a" type="main">MYCN in neuronal tumours</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Schwab</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Cancer Lett</title>
              <imprint>
                <biblScope unit="volume">204</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="179" to="87" unit="page"/>
                <date type="published" when="2004"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b20">
            <analytic>
              <title level="a" type="main">MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">L</forename>
                  <surname>Cohn</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">B</forename>
                  <surname>London</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Huang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">M</forename>
                  <surname>Katzenstein</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">R</forename>
                  <surname>Salwen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Reinhart</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Madafiglio</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">M</forename>
                  <surname>Marshall</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">D</forename>
                  <surname>Norris</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Haber</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Clin Oncol</title>
              <imprint>
                <biblScope unit="volume">18</biblScope>
                <biblScope unit="issue">21</biblScope>
                <biblScope from="3604" to="3617" unit="page"/>
                <date type="published" when="2000"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b21">
            <analytic>
              <title level="a" type="main">Molecular biology and genetics of human neuroblastoma</title>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">M</forename>
                  <surname>Brodeur</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">T</forename>
                  <surname>Fong</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Cancer Genet Cytogenet</title>
              <imprint>
                <biblScope unit="volume">41</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="153" to="74" unit="page"/>
                <date type="published" when="1989"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b22">
            <analytic>
              <title level="a" type="main">Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage</title>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">M</forename>
                  <surname>Brodeur</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">C</forename>
                  <surname>Seeger</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Schwab</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">E</forename>
                  <surname>Varmus</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Bishop</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Science</title>
              <imprint>
                <biblScope unit="volume">224</biblScope>
                <biblScope unit="issue">4653</biblScope>
                <biblScope from="1121" to="1125" unit="page"/>
                <date type="published" when="1984"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b23">
            <analytic>
              <title level="a" type="main">Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">C</forename>
                  <surname>Seeger</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">M</forename>
                  <surname>Brodeur</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Sather</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Dalton</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">E</forename>
                  <surname>Siegel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">Y</forename>
                  <surname>Wong</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Hammond</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">N Engl J Med</title>
              <imprint>
                <biblScope unit="volume">313</biblScope>
                <biblScope unit="issue">18</biblScope>
                <biblScope from="1111" to="1117" unit="page"/>
                <date type="published" when="1985"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b24">
            <analytic>
              <title level="a" type="main">MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma</title>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <forename type="middle">X</forename>
                  <surname>Yue</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Huang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Gao</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">Y</forename>
                  <surname>Xing</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">G</forename>
                  <surname>Liu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">X</forename>
                  <forename type="middle">J</forename>
                  <surname>Li</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Q</forename>
                  <surname>Zhao</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">X</forename>
                  <forename type="middle">S</forename>
                  <surname>Wang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <surname>Zhao</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Jin</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Cancer Cell Int</title>
              <imprint>
                <biblScope unit="volume">17</biblScope>
                <biblScope unit="page">43</biblScope>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b25">
            <analytic>
              <title level="a" type="main">Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's oncology group study</title>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">A</forename>
                  <surname>Moreau</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Mcgrady</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">B</forename>
                  <surname>London</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Shimada</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">L</forename>
                  <surname>Cohn</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Maris</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Diller</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">T</forename>
                  <surname>Look</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">E</forename>
                  <surname>George</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Clin Cancer Res</title>
              <imprint>
                <biblScope unit="volume">12</biblScope>
                <biblScope from="5693" to="5700" unit="page"/>
                <date type="published" when="2006"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b26">
            <analytic>
              <title level="a" type="main">Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">C</forename>
                  <surname>Favrot</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Ambros</forename>
                  <forename type="middle">P</forename>
                  <surname>Schilling</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Frappaz</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Combaret</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Berthold</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Dominici</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Erttmann</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Esteve</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Jenkner</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Ann Oncol</title>
              <imprint>
                <biblScope unit="volume">7</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="607" to="618" unit="page"/>
                <date type="published" when="1996"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b27">
            <analytic>
              <title level="a" type="main">Detection of N-myc amplification in neuroblastomas using southern blotting on fine needle aspirates</title>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Barroca</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">L</forename>
                  <surname>Carvalho</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">J</forename>
                  <surname>Da Costa</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Cirnes</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Seruca</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <forename type="middle">C</forename>
                  <surname>Schmitt</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Acta Cytol</title>
              <imprint>
                <biblScope unit="volume">45</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="169" to="72" unit="page"/>
                <date type="published" when="2001"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b28">
            <monogr>
              <title level="m" type="main">Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">C</forename>
                  <surname>Crabbe</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Peters</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">C</forename>
                  <surname>Seeger</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="1992"/>
                <biblScope unit="volume">1</biblScope>
                <biblScope from="229" to="263" unit="page"/>
              </imprint>
            </monogr>
            <note>Diagnostic molecular pathology : the American journal of surgical pathology, part B</note>
          </biblStruct>
          <biblStruct xml:id="b29">
            <analytic>
              <title level="a" type="main">MYCN amplification by differential PCR</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">N</forename>
                  <surname>Huddart</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">R</forename>
                  <surname>Mann</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">G</forename>
                  <surname>Mcgukin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Corbett</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Pediatr Hematol Oncol</title>
              <imprint>
                <biblScope unit="volume">10</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="31" to="35" unit="page"/>
                <date type="published" when="1993"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b30">
            <analytic>
              <title level="a" type="main">Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR</title>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Anderson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Gibson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Williamson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Rampling</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Austin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Shipley</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Sebire</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Brock</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Pediatr Blood Cancer</title>
              <imprint>
                <biblScope unit="volume">46</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="820" to="824" unit="page"/>
                <date type="published" when="2006"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b31">
            <monogr>
              <title level="m" type="main">Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">N</forename>
                  <surname>Misra</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <forename type="middle">S</forename>
                  <surname>Dickman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <forename type="middle">J</forename>
                  <surname>Yunis</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="1995"/>
                <biblScope unit="volume">4</biblScope>
                <biblScope from="128" to="163" unit="page"/>
              </imprint>
            </monogr>
            <note>Diagnostic molecular pathology : the American journal of surgical pathology, part B</note>
          </biblStruct>
          <biblStruct xml:id="b32">
            <monogr>
              <title level="m" type="main">Identification of MYCN copy number heterogeneity by direct FISH analysis of neuroblastoma preparations. Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology</title>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">A</forename>
                  <surname>Squire</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Thorner</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Marrano</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Parkinson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <forename type="middle">K</forename>
                  <surname>Ng</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Gerrie</forename>
                  <forename type="middle">B</forename>
                  <surname>Chilton-Macneill</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Zielenska</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                </persName>
              </author>
              <imprint>
                <date type="published" when="1996"/>
                <biblScope unit="volume">1</biblScope>
                <biblScope from="281" to="290" unit="page"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b33">
            <analytic>
              <title level="a" type="main">Automatic quantification of gene amplification in clinical samples by IQ-FISH</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Narath</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Lorch</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Rudas</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <forename type="middle">F</forename>
                  <surname>Ambros</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Cytometry B Clin Cytom</title>
              <imprint>
                <biblScope unit="volume">57</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="15" to="22" unit="page"/>
                <date type="published" when="2004"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b34">
            <monogr>
              <title level="m" type="main">Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Bhargava</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">O</forename>
                  <surname>Oppenheimer</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <surname>Gerald</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">C</forename>
                  <surname>Jhanwar</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Chen</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="2005"/>
                <biblScope unit="volume">14</biblScope>
                <biblScope from="72" to="78" unit="page"/>
              </imprint>
            </monogr>
            <note>Diagnostic molecular pathology : the American journal of surgical pathology, part B</note>
          </biblStruct>
          <biblStruct xml:id="b35">
            <analytic>
              <title level="a" type="main">Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients</title>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Hiyama</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <surname>Hiyama</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Yokoyama</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Ishii</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Pediatr Surg</title>
              <imprint>
                <biblScope unit="volume">26</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="838" to="881" unit="page"/>
                <date type="published" when="1991"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b36">
            <analytic>
              <title level="a" type="main">Augmented expression of MYC and/ or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's oncology group study</title>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">L</forename>
                  <surname>Wang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Teshiba</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Ikegaki</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">X</forename>
                  <forename type="middle">X</forename>
                  <surname>Tang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Naranjo</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">B</forename>
                  <surname>London</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">D</forename>
                  <surname>Hogarty</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Gastier-Foster</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">T</forename>
                  <surname>Look</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">R</forename>
                  <surname>Park</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Br J Cancer</title>
              <imprint>
                <biblScope unit="volume">113</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="57" to="63" unit="page"/>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b37">
            <analytic>
              <title level="a" type="main">Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan</title>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <forename type="middle">C</forename>
                  <surname>Wu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">I</forename>
                  <forename type="middle">C</forename>
                  <surname>Chang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">L</forename>
                  <surname>Wang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">D</forename>
                  <surname>Chen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <forename type="middle">T</forename>
                  <surname>Chen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">P</forename>
                  <surname>Liu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Chu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <forename type="middle">T</forename>
                  <surname>Chiu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">H</forename>
                  <surname>Wu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">H</forename>
                  <surname>Chou</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">PLoS One</title>
              <imprint>
                <biblScope unit="volume">8</biblScope>
                <biblScope unit="issue">8</biblScope>
                <biblScope unit="page">70839</biblScope>
                <date type="published" when="2013"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b38">
            <analytic>
              <title level="a" type="main">A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material</title>
              <author>
                <persName>
                  <forename type="first">Le</forename>
                  <surname>Quesne</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Maurya</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Yancheva</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">G</forename>
                  <surname>O&amp;apos;brien</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Popat</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Wotherspoon</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">C</forename>
                  <surname>De Castro</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">G</forename>
                  <surname>Nicholson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">G</forename>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Thorac Oncol</title>
              <imprint>
                <biblScope unit="volume">9</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="769" to="74" unit="page"/>
                <date type="published" when="2014"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b39">
            <analytic>
              <title level="a" type="main">Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">A</forename>
                  <surname>Eastmond</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Schuler</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">S</forename>
                  <surname>Rupa</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Mutat Res</title>
              <imprint>
                <biblScope unit="volume">348</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="153" to="62" unit="page"/>
                <date type="published" when="1995"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b40">
            <analytic>
              <title level="a" type="main">Droplet digital PCR quantitation of HER2 expression in FFPE breast cancer samples</title>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <forename type="middle">J</forename>
                  <surname>Heredia</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Belgrader</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Wang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Koehler</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Regan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">M</forename>
                  <surname>Cosman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Saxonov</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Hindson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">C</forename>
                  <surname>Tanner</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">S</forename>
                  <surname>Brown</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Methods</title>
              <imprint>
                <biblScope unit="volume">59</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="20" to="23" unit="page"/>
                <date type="published" when="2013"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b41">
            <analytic>
              <title level="a" type="main">Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">K</forename>
                  <surname>Ramraj</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">T</forename>
                  <surname>Somasundaram</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Biomed Sci</title>
              <imprint>
                <biblScope unit="volume">22</biblScope>
                <biblScope unit="page">28</biblScope>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b42">
            <analytic>
              <title level="a" type="main">Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells</title>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <forename type="middle">H</forename>
                  <surname>Khan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Pandian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Ramraj</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">S</forename>
                  <surname>Herman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">BMC Genomics</title>
              <imprint>
                <biblScope unit="volume">16</biblScope>
                <biblScope unit="page">501</biblScope>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b43">
            <analytic>
              <title level="a" type="main">RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes</title>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <forename type="middle">H</forename>
                  <surname>Khan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Pandian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">K</forename>
                  <surname>Ramraj</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Natarajan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Azadi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">S</forename>
                  <surname>Herman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Oncotarget</title>
              <imprint>
                <biblScope unit="volume">6</biblScope>
                <biblScope unit="issue">34</biblScope>
                <biblScope from="36522" to="36556" unit="page"/>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b44">
            <analytic>
              <title level="a" type="main">Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes</title>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <forename type="middle">H</forename>
                  <surname>Khan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Pandian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Ramraj</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Natarajan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">S</forename>
                  <surname>Herman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Aravindan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">BMC Cancer</title>
              <imprint>
                <biblScope unit="volume">15</biblScope>
                <biblScope unit="page">514</biblScope>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b45">
            <analytic>
              <title level="a" type="main">Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Schwab</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">E</forename>
                  <surname>Varmus</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Bishop</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Nature</title>
              <imprint>
                <biblScope unit="volume">316</biblScope>
                <biblScope unit="issue">6024</biblScope>
                <biblScope from="160" to="162" unit="page"/>
                <date type="published" when="1985"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b46">
            <analytic>
              <title level="a" type="main">MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Corvi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">C</forename>
                  <surname>Amler</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Savelyeva</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Gehring</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Schwab</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Proc Natl Acad Sci</title>
              <imprint>
                <biblScope unit="volume">91</biblScope>
                <biblScope unit="issue">12</biblScope>
                <biblScope from="5523" to="5530" unit="page"/>
                <date type="published" when="1994"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b47">
            <monogr>
              <title level="m" type="main">Human neuroblastoma: amplification of the N-myc oncogene and loss of a putative cancer-preventing gene on chromosome 1p. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Schwab</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="1994"/>
                <biblScope unit="volume">135</biblScope>
                <biblScope from="7" to="16" unit="page"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b48">
            <analytic>
              <title level="a" type="main">cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma</title>
              <author>
                <persName>
                  <forename type="first">Q</forename>
                  <forename type="middle">R</forename>
                  <surname>Chen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Bilke</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">S</forename>
                  <surname>Wei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">C</forename>
                  <surname>Whiteford</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Cenacchi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">L</forename>
                  <surname>Krasnoselsky</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <forename type="middle">T</forename>
                  <surname>Greer</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">G</forename>
                  <surname>Son</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Westermann</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Berthold</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">BMC Genomics</title>
              <imprint>
                <biblScope unit="volume">5</biblScope>
                <biblScope unit="page">70</biblScope>
                <date type="published" when="2004"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b49">
            <analytic>
              <title level="a" type="main">MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children</title>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">P</forename>
                  <surname>Tonini</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Boni</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Pession</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Rogers</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Iolascon</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Basso</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Cordero</forename>
                  <surname>Di Montezemolo</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Casale</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Pession</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Perri</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Clin Oncol</title>
              <imprint>
                <biblScope unit="volume">15</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="85" to="93" unit="page"/>
                <date type="published" when="1997"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b50">
            <analytic>
              <title level="a" type="main">Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis</title>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Wang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Jys</forename>
                  <surname>Tsang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Cui</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Cui</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Lin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Zhao</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Ptw</forename>
                  <surname>Law</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">Y</forename>
                  <surname>Cheung</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Eko</forename>
                  <surname>Ng</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Gmk</forename>
                  <surname>Tse</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Sci Rep</title>
              <imprint>
                <biblScope unit="volume">7</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope unit="page">6752</biblScope>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b51">
            <analytic>
              <title level="a" type="main">Droplet digital PCR measurement of HER2 in patients with gastric cancer</title>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Kinugasa</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <surname>Nouso</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Tanaka</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <surname>Miyahara</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Morimoto</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Dohi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Matsubara</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Okada</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <surname>Yamamoto</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Br J Cancer</title>
              <imprint>
                <biblScope unit="volume">112</biblScope>
                <biblScope unit="issue">10</biblScope>
                <biblScope from="1652" to="1657" unit="page"/>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b52">
            <analytic>
              <title level="a" type="main">Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients</title>
              <author>
                <persName>
                  <forename type="first">X</forename>
                  <surname>Li</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Liu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <surname>Shi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Xu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Hu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <surname>Dong</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Zhu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Sun</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Liu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Gao</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Clin Chim Acta</title>
              <imprint>
                <biblScope unit="volume">471</biblScope>
                <biblScope from="177" to="84" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b53">
            <analytic>
              <title level="a" type="main">Quantitative and sensitive detection of Cancer genome amplifications from formalin fixed paraffin embedded tumors with droplet digital PCR</title>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Nadauld</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">F</forename>
                  <surname>Regan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Miotke</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">K</forename>
                  <surname>Pai</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">A</forename>
                  <surname>Longacre</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">S</forename>
                  <surname>Kwok</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Saxonov</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">M</forename>
                  <surname>Ford</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">P</forename>
                  <surname>Ji</surname>
                </persName>
              </author>
              <idno type="DOI">10.4172/2161-1025.1000107</idno>
              <ptr target="https://doi.org/10.4172/2161-1025.1000107"/>
            </analytic>
            <monogr>
              <title level="j">Transl Med (Sunnyvale)</title>
              <imprint>
                <biblScope unit="volume">2</biblScope>
                <biblScope unit="issue">2</biblScope>
                <date type="published" when="2012"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b54">
            <analytic>
              <title level="a" type="main">Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples</title>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Zhu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Lu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">E</forename>
                  <surname>Lira</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Q</forename>
                  <surname>Xu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Du</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Xiong</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mao</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">C</forename>
                  <surname>Chung</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Zheng</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Exp Mol Pathol</title>
              <imprint>
                <biblScope unit="volume">100</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="287" to="93" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b55">
            <analytic>
              <title level="a" type="main">High-throughput droplet digital PCR system for absolute quantitation of DNA copy number</title>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <forename type="middle">J</forename>
                  <surname>Hindson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">D</forename>
                  <surname>Ness</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">A</forename>
                  <surname>Masquelier</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Belgrader</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <forename type="middle">J</forename>
                  <surname>Heredia</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">J</forename>
                  <surname>Makarewicz</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">I</forename>
                  <forename type="middle">J</forename>
                  <surname>Bright</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">Y</forename>
                  <surname>Lucero</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">L</forename>
                  <surname>Hiddessen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">C</forename>
                  <surname>Legler</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Anal Chem</title>
              <imprint>
                <biblScope unit="volume">83</biblScope>
                <biblScope unit="issue">22</biblScope>
                <biblScope from="8604" to="8614" unit="page"/>
                <date type="published" when="2011"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b56">
            <analytic>
              <title level="a" type="main">HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement</title>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">W</forename>
                  <surname>Jacobs</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">M</forename>
                  <surname>Gown</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Yaziji</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">J</forename>
                  <surname>Barnes</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">J</forename>
                  <surname>Schnitt</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Am J Clin Pathol</title>
              <imprint>
                <biblScope unit="volume">113</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="251" to="259" unit="page"/>
                <date type="published" when="2000"/>
              </imprint>
            </monogr>
          </biblStruct>
        </listBibl>
      </div>
    </back>
  </text>
</TEI>
